TM editors’ note: This article discusses a penny stock and/or microcap. Such stocks are easily manipulated; do your own careful due diligence.

Canadian cannabis stocks have been one of the most attractive places to invest as the country prepares to legalize recreational marijuana before July 2018.This has made the Canadian cannabis market one of the hottest markets and we are favorable on this opportunity. During the last quarter, we have seen a significant amount of capital enter the Canadian sector and we do not expect this trend to end anytime soon. From Constellation Brands’ $250 million investment into Canopy Growth (WEED.TO) (TWMJF) to Aurora Cannabis’ (ACB.TO) (ACBFF) planned acquisition of CanniMed Therapeutics (CMED.TO) (CMMDF), there are several factors driving the Canadian cannabis market higher.

Today, we have highlighted 5 company developments that we find to be significant and will monitor how the market trades today.

Aurora-CanniMed Hearing to Take Place on Wednesday

Last week, the Ontario Securities Commission (OSC) issued a notice of hearing to consider the application filed by Cannimed Therapeutics (CMED.TO) (CMMDF) to intervene in Aurora Cannabis’ (ACB.TO) (ACBFF) attempted acquisition. The hearing is set for Wednesday and cannabis investors will be monitoring this development closely. CanniMed does not want this acquisition to go through and has been working on getting this deal rejected. We would be bullish on the combined company and see tremendous opportunity for synergies. Both companies are capitalizing on two of the most significant trends in the cannabis industry, international markets and cannabis oils. Aurora has a war chest of a cash, strategic relationships, and significant infrastructure in Canada and abroad. If this deal is completed, Aurora would significantly enhance and expand CanniMed’s global reach. Aurora has made strategic investments in Hempco Food and Fiber Inc. (HEMP.V) and Radient Technologies (RTI.V), which would significantly benefit the combined company. We are favorable on these investments and the benefit they would have on CanniMed’s cannabis oil business. The combined company would have the capital and resources to execute on the global medical marijuana market and we are bullish on this opportunity.

Print Friendly, PDF & Email